The DOI matches its Crossref record; the references it cites are not checked yet.
Impact of Growth Hormone (GH) Treatment on Cardiovascular Risk Factors in GH-Deficient Adults: A Metaanalysis of Blinded, Randomized, Placebo-Controlled Trials
Open accessAbstract
Patients with hypopituitarism have an increased risk of cardiovascular mortality. GH treatment could modify the cardiovascular risk in adults with GH deficiency, but most published clinical trials involved few patients and the results are variable. We conducted a systematic review of blinded, randomized, placebo-controlled trials of GH treatment in adult patients with GH deficiency published up to August 2003. Thirty-seven trials were identified. We combined the results for effects on lean and fat body mass; body mass index; triglyceride and cholesterol [high-density lipoprotein, low-density lipoprotein (LDL), and total] levels; blood pressure; glycemia; and insulinemia. Overall effect size was used to evaluate significance, and weighted differences between GH and placebo were used to appreciate the size of the effect. GH treatment significantly reduced LDL cholesterol [−0.5 (sd 0.3) mmol/liter], total cholesterol [−0.3 (0.3) mmol/liter], fat mass [−3.1 (3.3) kg], and diastolic blood pressure [−1.8 (3.8) mm Hg] and significantly increased lean body mass [+2.7 (2.6) kg], fasting plasma glucose [+0.2 (0.1) mmol/liter], and insulin [+8.7 (7.0) pmol/liter]. All effect sizes remained significant in trials with low doses and long-duration GH treatment. Thus, GH treatment has beneficial effects on lean and fat body mass, total and LDL cholesterol levels, and diastolic blood pressure but reduces insulin sensitivity. The global cardiovascular benefit remains to be determined in large trials with appropriate clinical endpoints.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
The citation lists are queued
They are fetched later and appear here then.
References 68 · Cited by 362
Research works printed but not linked: 2
- J Clin Endocrinol Metab, 83, 379
- Bell, 1998, Effect of growth hormone on total body potassium, fat-free mass and strength in growth hormone-deficient males., J Sports Sci, 16, 36
Metadata
- Authors
- Maison, P., Griffin, S., Nicoue-Beglah, M., Haddad, N., Balkau, B., & Chanson, P.
- Affiliations
- Inserm (FR)
- University of Cambridge (GB)
- Assistance Publique – Hôpitaux de Paris (FR)
- Corresponding author
- Chanson, Philippe
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2004-05-01
- Volume
- 89
- Issue
- 5
- Pages
- 2192-2199
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2036286877
- Semantic Scholar
- ab41e1b51a1e150057dc1c34d5eb32087e2a78df
- Cited by
- 362
- References
- 68
- Citations by year
- 2026: 9 · 2025: 13 · 2024: 5 · 2023: 15 · 2022: 20 · 2021: 17 · 2020: 15 · 2019: 10 · 2018: 16 · 2017: 12 · 2016: 15 · 2015: 10 · 2014: 21 · 2013: 21 · 2012: 19
- FWCI
- 2.55
- Type
- journal article
- Language
- en
- Open access
- green
- hal.inrae.fr
- Licence
- other-oa
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Keywords
- growth hormone therapy, adult growth hormone deficiency, hypopituitarism, cardiovascular risk factors, LDL cholesterol, total cholesterol, triglycerides, body mass index, fat mass, lean body mass, blood pressure, fasting blood glucose, insulin sensitivity, insulin levels
- MeSH terms
- Adult, Aged, Blood Glucose, Blood Pressure, Body Composition, Cardiovascular Diseases, Dose-Response Relationship, Drug, Double-Blind Method, Drug Administration Schedule, Female, Humans, Insulin, Lipids, Male, Metabolism, Inborn Errors, Middle Aged, Placebos, Risk Factors, Growth Hormone, Randomized Controlled Trials as Topic, Human Growth Hormone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Impact of Growth Hormone (GH) Treatment on Cardiovascular Risk Factors in GH-Deficient Adults: A Metaanalysis of Blinded, Randomized, Placebo-Controlled Trials. https://app.cochat.ai/papers/10.1210/jc.2003-030840
- The paper
- Maison, P., Griffin, S., Nicoue-Beglah, M., Haddad, N., Balkau, B., & Chanson, P. (2004). Impact of Growth Hormone (GH) Treatment on Cardiovascular Risk Factors in GH-Deficient Adults: A Metaanalysis of Blinded, Randomized, Placebo-Controlled Trials. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2003-030840
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.